Determining Risk Factors for Pellagra during the Isoniazid Preventive Therapy Scale-up in Malawi

Data Collection Period: 02/2019 – 08/2019

The primary objective of this CDC-sponsored prospective study was to determine whether exposure to isoniazid (INH) is associated with the development of pellagra in Malawi.

Publications and Presentations

Paper published in Lancet Global Health May 2022: “Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study”